PharmGKB summary: very important pharmacogene information for PTGS2
- PMID: 21063235
- PMCID: PMC3141084
- DOI: 10.1097/FPC.0b013e3283415515
PharmGKB summary: very important pharmacogene information for PTGS2
Similar articles
-
Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.Breast Cancer Res Treat. 2012 Feb;132(1):251-8. doi: 10.1007/s10549-011-1828-0. Epub 2011 Oct 30. Breast Cancer Res Treat. 2012. PMID: 22037828
-
PharmGKB summary: very important pharmacogene information for CYP2B6.Pharmacogenet Genomics. 2010 Aug;20(8):520-3. doi: 10.1097/fpc.0b013e32833947c2. Pharmacogenet Genomics. 2010. PMID: 20648701 Free PMC article. No abstract available.
-
Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.Arch Dermatol Res. 2012 Jul;304(5):335-42. doi: 10.1007/s00403-011-1194-0. Epub 2011 Dec 8. Arch Dermatol Res. 2012. PMID: 22159575
-
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.Pharmacogenet Genomics. 2013 Dec;23(12):721-8. doi: 10.1097/FPC.0b013e3283653b27. Pharmacogenet Genomics. 2013. PMID: 23962911 Free PMC article. Review. No abstract available.
-
PharmGKB summary: very important pharmacogene information for UGT1A1.Pharmacogenet Genomics. 2014 Mar;24(3):177-83. doi: 10.1097/FPC.0000000000000024. Pharmacogenet Genomics. 2014. PMID: 24492252 Free PMC article. Review. No abstract available.
Cited by
-
Exploring the pathogenesis of chronic atrophic gastritis with atherosclerosis via microarray data analysis.Medicine (Baltimore). 2024 Apr 19;103(16):e37798. doi: 10.1097/MD.0000000000037798. Medicine (Baltimore). 2024. PMID: 38640295 Free PMC article.
-
Colorectal cancer drug target prediction using ontology-based inference and network analysis.Database (Oxford). 2015 Mar 27;2015:bav015. doi: 10.1093/database/bav015. Print 2015. Database (Oxford). 2015. PMID: 25818893 Free PMC article.
-
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.Biomark Med. 2011 Dec;5(6):795-806. doi: 10.2217/bmm.11.94. Biomark Med. 2011. PMID: 22103613 Free PMC article. Review.
-
Celecoxib pathways: pharmacokinetics and pharmacodynamics.Pharmacogenet Genomics. 2012 Apr;22(4):310-8. doi: 10.1097/FPC.0b013e32834f94cb. Pharmacogenet Genomics. 2012. PMID: 22336956 Free PMC article. No abstract available.
-
Genetic markers of thrombophilia as predictors of outcome in colorectal cancer.J Thromb Thrombolysis. 2025 Jun;58(5):663-678. doi: 10.1007/s11239-025-03106-1. Epub 2025 May 27. J Thromb Thrombolysis. 2025. PMID: 40425987 Free PMC article.
References
-
- Grosser T, Yu Y, Fitzgerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med. 2010;61:17–33. - PubMed
-
- Couzin J. Drug safety: withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science. 2004;306:384–385. - PubMed
-
- Lipsky PE, Brooks P, Crofford LJ, DuBois R, Graham D, Simon LS, et al. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease. Arch Intern Med. 2000;160:913–920. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials